BlackRock Fund Advisors’s RESPONSE GENETICS, INC COMMON SHS (DELAWARE) RGDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
Sell
-109,847
Closed -$131K 3935
2014
Q1
$131K Buy
109,847
+48,244
+78% +$67.3K ﹤0.01% 3551
2013
Q4
$71K Buy
61,603
+2,580
+4% +$4.23K ﹤0.01% 3616
2013
Q3
$131K Buy
59,023
+4,644
+9% +$9.38K ﹤0.01% 3505
2013
Q2
$83K Buy
+54,379
New +$74K ﹤0.01% 3553

Other funds holding RGDX

BlackRock Fund Advisors's RGDX Position: Q2 2014 in Review

BlackRock Fund Advisors sold out of RESPONSE GENETICS, INC COMMON SHS (DELAWARE) (RGDX) in Q2 2014, closing a stake of 109,847 shares — an estimated $131K sold.

BlackRock Fund Advisors first reported a position in RGDX in Q2 2013 and held it in 4 quarters. The position peaked at $131K in Q1 2014. 22 funds tracked by Wall St. Rank hold RGDX as of Q2 2014.

  • BlackRock Fund Advisors reported no remaining RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position as of Q2 2014 after selling out during the quarter.
  • BlackRock Fund Advisors sold 109,847 RESPONSE GENETICS, INC COMMON SHS (DELAWARE) shares in Q2 2014, an estimated $131K.
  • BlackRock Fund Advisors first reported a position in RESPONSE GENETICS, INC COMMON SHS (DELAWARE) in Q2 2013 and held it in 4 quarters.
  • BlackRock Fund Advisors's RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position peaked at $131K in Q1 2014.
  • 22 funds tracked by Wall St. Rank held RESPONSE GENETICS, INC COMMON SHS (DELAWARE) as of Q2 2014.

Based on BlackRock Fund Advisors's 13F filing for Q2 2014, filed 6 Aug 2014.